Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 3
2001 2
2002 3
2003 2
2004 3
2005 8
2006 1
2007 9
2008 4
2009 3
2010 4
2011 2
2012 3
2013 10
2014 12
2015 12
2016 19
2017 7
2018 20
2019 25
2020 27
2021 29
2022 22
2023 25
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.
Burstein R, Henry NJ, Collison ML, Marczak LB, Sligar A, Watson S, Marquez N, Abbasalizad-Farhangi M, Abbasi M, Abd-Allah F, Abdoli A, Abdollahi M, Abdollahpour I, Abdulkader RS, Abrigo MRM, Acharya D, Adebayo OM, Adekanmbi V, Adham D, Afshari M, Aghaali M, Ahmadi K, Ahmadi M, Ahmadpour E, Ahmed R, Akal CG, Akinyemi JO, Alahdab F, Alam N, Alamene GM, Alene KA, Alijanzadeh M, Alinia C, Alipour V, Aljunid SM, Almalki MJ, Al-Mekhlafi HM, Altirkawi K, Alvis-Guzman N, Amegah AK, Amini S, Amit AML, Anbari Z, Androudi S, Anjomshoa M, Ansari F, Antonio CAT, Arabloo J, Arefi Z, Aremu O, Armoon B, Arora A, Artaman A, Asadi A, Asadi-Aliabadi M, Ashraf-Ganjouei A, Assadi R, Ataeinia B, Atre SR, Quintanilla BPA, Ayanore MA, Azari S, Babaee E, Babazadeh A, Badawi A, Bagheri S, Bagherzadeh M, Baheiraei N, Balouchi A, Barac A, Bassat Q, Baune BT, Bayati M, Bedi N, Beghi E, Behzadifar M, Behzadifar M, Belay YB, Bell B, Bell ML, Berbada DA, Bernstein RS, Bhattacharjee NV, Bhattarai S, Bhutta ZA, Bijani A, Bohlouli S, Breitborde NJK, Britton G, Browne AJ, Nagaraja SB, Busse R, Butt ZA, Car J, Cárdenas R, Castañeda-Orjuela CA, Cerin E, Chanie WF, Chatterjee P, Chu DT, Cooper C, Costa VM, Dalal K, Dan… See abstract for full author list ➔ Burstein R, et al. Nature. 2019 Oct;574(7778):353-358. doi: 10.1038/s41586-019-1545-0. Epub 2019 Oct 16. Nature. 2019. PMID: 31619795 Free PMC article.
Retraction Statement: Novel NAD-independent Avibacterium paragallinarum: Isolation, characterization and molecular identification in Iran.
[No authors listed] [No authors listed] Vet Med Sci. 2023 Sep;9(5):2390. doi: 10.1002/vms3.1257. Epub 2023 Sep 15. Vet Med Sci. 2023. PMID: 37713440 Free PMC article.
Beiranvand, S., Piri-Gharaghie, T., Dehganzad, B., Khedmati, F., Jalali, F., AsadAlizadeh, M., & Momtaz, H. (2022). Novel NAD-independent Avibacterium paragallinarum: Isolation, characterization and molecular identification in Iran. ...
Beiranvand, S., Piri-Gharaghie, T., Dehganzad, B., Khedmati, F., Jalali, F., AsadAlizadeh, M., & Momtaz, H. (2022). Novel …
The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
Jalali S, Ansell SM. Jalali S, et al. Hematol Oncol Clin North Am. 2018 Oct;32(5):777-786. doi: 10.1016/j.hoc.2018.05.005. Epub 2018 Jul 25. Hematol Oncol Clin North Am. 2018. PMID: 30190017 Review.
Waldenstrom macroglobulinemia (WM) is an indolent B-cell lymphoma defined predominantly by infiltration of lymphoplasmacytic cells into the bone marrow (BM) and increased production of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells, and the secretion of IgM i …
Waldenstrom macroglobulinemia (WM) is an indolent B-cell lymphoma defined predominantly by infiltration of lymphoplasmacytic cells into the …
Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
Jalali S, Ansell SM. Jalali S, et al. Best Pract Res Clin Haematol. 2016 Jun;29(2):148-155. doi: 10.1016/j.beha.2016.08.016. Epub 2016 Sep 4. Best Pract Res Clin Haematol. 2016. PMID: 27825460 Review.
A second characteristic associated with WM is the increased synthesis of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells, which is secreted in the serum and often results in hyperviscosity. ...
A second characteristic associated with WM is the increased synthesis of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells …
Rapid Emergency Medicine Score as a Predictive Value for 30-day Outcome of Nonsurgical Patients Referred to the Emergency Department.
Ala A, Vahdati SS, Jalali M, Parsay S. Ala A, et al. Indian J Crit Care Med. 2020 Jun;24(6):418-422. doi: 10.5005/jp-journals-10071-23456. Indian J Crit Care Med. 2020. PMID: 32863634 Free PMC article.
CONCLUSION: In sum, the outcomes of the present study corroborate the REMS system as a successful scale in predicting mortality and the duration of hospitalization in nonsurgical ED patients. HOW TO CITE THIS ARTICLE: Ala A, Vahdati SS, Jalali M, Parsay S. Rapid Eme …
CONCLUSION: In sum, the outcomes of the present study corroborate the REMS system as a successful scale in predicting mortality and the dura …
Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.
Wang L, Wang Y, Chen A, Teli M, Kondo R, Jalali A, Fan Y, Liu S, Zhao X, Siegel A, Minami K, Agarwal M, Li BY, Yokota H. Wang L, et al. FASEB J. 2019 Dec;33(12):13710-13721. doi: 10.1096/fj.201901388R. Epub 2019 Oct 4. FASEB J. 2019. PMID: 31585508 Free PMC article.
Collectively, the results lay a foundation for further investigation of pitavastatin's therapeutic efficacy in tumor-induced bone loss, as well as VOC-based diagnosis of tumor progression and treatment efficacy.-Wang, L., Wang, Y., Chen, A., Teli, M., Kondo, R., Jalali …
Collectively, the results lay a foundation for further investigation of pitavastatin's therapeutic efficacy in tumor-induced bone loss, as w …
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies.
Mondello P, Paludo J, Novak JP, Wenzl K, Yang ZZ, Jalali S, Krull JE, Braggio E, Dasari S, Manske MK, Abeykoon JA, Sarangi V, Kapoor P, Paulus A, Reeder CB, Ailawadhi S, Chanan-Khan AA, Kyle RA, Gertz MA, Novak AJ, Ansell SM. Mondello P, et al. Clin Cancer Res. 2023 Mar 1;29(5):957-970. doi: 10.1158/1078-0432.CCR-22-2215. Clin Cancer Res. 2023. PMID: 36534518
Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma.
Patil VM, Bhelekar A, Menon N, Bhattacharjee A, Simha V, Abhinav R, Abhyankar A, Sridhar E, Mahajan A, Puranik AD, Purandare N, Janu A, Ahuja A, Krishnatry R, Gupta T, Jalali R. Patil VM, et al. Cancer Med. 2020 Jul;9(13):4676-4685. doi: 10.1002/cam4.3094. Epub 2020 May 13. Cancer Med. 2020. PMID: 32400117 Free PMC article. Clinical Trial.
Patients eligible for re-irradiation were enrolled in arm A1 (radiation with concurrent temozolomide 75 mg/m(2) daily during the course of radiation+mebendazole) while patients who were ineligible were enrolled in either arm B1 (CCNU 110 mg/m(2) day 1, every 6 weekl …
Patients eligible for re-irradiation were enrolled in arm A1 (radiation with concurrent temozolomide 75 mg/m(2) daily during the cour …
230 results